首页> 外国专利> SUBUNIT-SELECTIVE NUCLEIC ACID INHIBITORS OF GLUTAMATE RECEPTORS

SUBUNIT-SELECTIVE NUCLEIC ACID INHIBITORS OF GLUTAMATE RECEPTORS

机译:谷氨酸受体的亚单位选择性核酸抑制剂

摘要

Inhibitors of AMPA-type glutamate ion channels are useful as biochemical probes for structure-function studies and as drug candidates for a number of neurological disorders and diseases. Disclosed herein is the identification of an RNA inhibitor or aptamer by an in vitro evolution approach and characterization of its mechanism of inhibition on the sites of interaction by equilibrium binding and on the receptor channel-opening rate by a laser-pulse photolysis technique. The aptamer of the invention is a noncompetitive inhibitor of AMPA-type glutamate ion channels, one that selectively inhibits the GluA2Qflip AMPA receptor subunit without any effect on other AMPA receptor subunits or on kainate or NMDA receptors. Furthermore, the aptamer preferentially inhibits the closed-channel state of GluA2Qflip with a KI=1.5 μM or by ˜15-fold over the open-channel state. The potency and selectivity of this aptamer rival those of small molecule inhibitors. Together, these properties make the aptamers of the present invention promising water-soluble, highly potent, GluA2 subunit-selective drugs.
机译:AMPA型谷氨酸离子通道的抑制剂可用作结构功能研究的生化探针,也可用作许多神经系统疾病和疾病的候选药物。本文公开了通过体外进化方法鉴定RNA抑制剂或适体,并通过激光结合光解技术通过平衡结合和在受体通道开放率上表征其抑制作用机理。本发明的适体是AMPA型谷氨酸离子通道的非竞争性抑制剂,其选择性抑制GluA2Q Flip AMPA受体亚基,而对其他AMPA受体亚基或海藻酸盐或NMDA受体没有任何影响。此外,适体优先抑制GluA2Q flip 的闭通道状态,其K I = 1.5μM或比开通道状态高约15倍。该适体的效力和选择性可与小分子抑制剂相媲美。这些特性一起使本发明的适体成为有前景的水溶性,高效力的GluA2亚基选择性药物。

著录项

  • 公开/公告号US2013289100A1

    专利类型

  • 公开/公告日2013-10-31

    原文格式PDF

  • 申请/专利权人 LI NIU;ZHEN HUANG;JAE SEON PARK;

    申请/专利号US201113810572

  • 发明设计人 LI NIU;ZHEN HUANG;JAE SEON PARK;

    申请日2011-07-15

  • 分类号C12N15/115;

  • 国家 US

  • 入库时间 2022-08-21 16:49:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号